3951 - 4000 of 5898 Results
Title
Year
-
OPENTitle: Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 1Start Page: 96End Page: 104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25376Best OA location URL: https://europepmc.org/articles/pmc6342624?pdf=renderCitation Count: 36
-
OPENTitle: Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progressionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-35130-yBest OA location URL: https://www.nature.com/articles/s41598-018-35130-y.pdfCitation Count: 44
- A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain2018OPENTitle: A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brainJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.40202Best OA location URL: https://doi.org/10.7554/elife.40202Citation Count: 222
- Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates2018OPENTitle: Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman PrimatesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1544End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00526Best OA location URL: https://europepmc.org/articles/pmc6810685?pdf=renderCitation Count: 95
-
OPENTitle: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 124Issue #:Start Page: 163End Page: 175Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002Best OA location URL: https://www.repository.cam.ac.uk/bitstream/1810/287349/1/YNBDI_2018_257_Original_V0-2-4-72.pdfCitation Count: 42
-
OPENTitle: RAB7A phosphorylation by TBK1 promotes mitophagy via the PINK-PARKIN pathwayJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 4Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aav0443Best OA location URL: https://advances.sciencemag.org/content/advances/4/11/eaav0443.full.pdfCitation Count: 162
- Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure2018OPENTitle: Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter MicrostructureJournal Name: Frontiers in EndocrinologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fendo.2018.00608Best OA location URL: https://www.frontiersin.org/articles/10.3389/fendo.2018.00608/pdfCitation Count: 17
- Dissociation between urate and blood pressure in mice and in people with early Parkinson's disease2018OPENTitle: Dissociation between urate and blood pressure in mice and in people with early Parkinson's diseaseJournal Name: EBioMedicinePublisher: Elsevier BVVol: 37Issue #:Start Page: 259End Page: 268Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2018.10.039Best OA location URL: http://www.thelancet.com/article/S2352396418304572/pdfCitation Count: 9
-
OPENTitle: Phosphorylation of Parkin at serine 65 is essential for its activationin vivoJournal Name: Open BiologyPublisher: The Royal SocietyVol: 8Issue #: 11Start Page: 180108End Page: 180108Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1098/rsob.180108Best OA location URL: https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.180108Citation Count: 108
- The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN212018OPENTitle: The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21Journal Name: Cell ReportsPublisher: Elsevier BVVol: 25Issue #: 9Start Page: 2484End Page: 2496.e9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2018.11.002Best OA location URL: http://www.cell.com/article/S2211124718317315/pdfCitation Count: 34
- Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice2018OPENTitle: Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in miceJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 465Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aah4066Best OA location URL: https://stm.sciencemag.org/content/scitransmed/10/465/eaah4066.full.pdfCitation Count: 687
-
OPENTitle: Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s DiseaseJournal Name: MetabolitesPublisher: MDPI AGVol: 8Issue #: 4Start Page: 71End Page: 71Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/metabo8040071Best OA location URL: https://www.mdpi.com/2218-1989/8/4/71/pdfCitation Count: 51
-
OPENTitle: The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohortJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 5Issue #: 12Start Page: 1460End Page: 1477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.644Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.644Citation Count: 440
-
OPENTitle: The vermiform appendix impacts the risk of developing Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 465Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5280Best OA location URL: https://stm.sciencemag.org/content/scitransmed/10/465/eaar5280.full.pdfCitation Count: 242
- δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer’s disease2018OPENTitle: δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer’s diseaseJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 26Issue #: 2Start Page: 586End Page: 603Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0286-zBest OA location URL: https://europepmc.org/articles/pmc6684859?pdf=renderCitation Count: 69
- A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein2018OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 50
-
OPENTitle: Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammationJournal Name: GliaPublisher: WileyVol: 66Issue #: 11Start Page: 2427End Page: 2437Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/glia.23482Best OA location URL: https://europepmc.org/articles/pmc6275110?pdf=renderCitation Count: 47
- The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis2018OPENTitle: The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early DiagnosisJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00326Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00326/pdfCitation Count: 77
- Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 42018OPENTitle: Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4Journal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1337-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1337-8Citation Count: 39
- The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s disease2018OPENTitle: The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-34490-9Best OA location URL: https://www.nature.com/articles/s41598-018-34490-9.pdfCitation Count: 137
-
OPENTitle: A comprehensive screening of copy number variability in dementia with Lewy bodiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 75Issue #:Start Page: 223.e1End Page: 223.e10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.10.019Best OA location URL: http://rihuc.huc.min-saude.pt/bitstream/10400.4/2247/1/comprehensive.pdfCitation Count: 16
- The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of events2018OPENTitle: The transition between turning and sitting in patients with Parkinson's disease: A wearable device detects an unexpected sequence of eventsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 67Issue #:Start Page: 224End Page: 229Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2018.10.018Best OA location URL: https://europepmc.org/articles/pmc6287952?pdf=renderCitation Count: 32
- Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers2018OPENTitle: Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 15Issue #: 2Start Page: 232End Page: 244Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.08.012Best OA location URL: https://pure.eur.nl/files/48163974/Repub_115206_O-A.pdfCitation Count: 268
- Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies2018OPENTitle: Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathiesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 28Issue #: 4Start Page: 548End Page: 560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy365Best OA location URL: https://academic.oup.com/hmg/article-pdf/28/4/548/27636558/ddy365.pdfCitation Count: 63
- Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress2018OPENTitle: Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stressJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 144Issue #:Start Page: 19End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.10.013Best OA location URL: https://europepmc.org/articles/pmc6286225?pdf=renderCitation Count: 52
-
OPENTitle: Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-33921-xBest OA location URL: https://www.nature.com/articles/s41598-018-33921-x.pdfCitation Count: 97
- Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse Brain2018OPENTitle: Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse BrainJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 11Issue #: 5Start Page: 1156End Page: 1170Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2018.09.004Best OA location URL: http://www.cell.com/article/S2213671118303898/pdfCitation Count: 43
- Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease2018OPENTitle: Validation of a performance‐based assessment of cognitive functional ability in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1760End Page: 1768Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27487Best OA location URL: https://europepmc.org/articles/pmc6261681?pdf=renderCitation Count: 18
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference2018OPENTitle: Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage InferenceJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-018-05892-0Best OA location URL: https://www.nature.com/articles/s41467-018-05892-0.pdfCitation Count: 392
-
OPENTitle: Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s DiseaseJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 18Issue #: 2Start Page: 212End Page: 224Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-018-0981-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-018-0981-y.pdfCitation Count: 17
- Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data2018OPENTitle: Progressive Decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging DataJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00318Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00318/pdfCitation Count: 69
- Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 22018OPENTitle: Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2Journal Name: Neurochemical ResearchPublisher: Springer Science and Business Media LLCVol: 44Issue #: 6Start Page: 1446End Page: 1459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11064-018-2650-4Best OA location URL: https://europepmc.org/articles/pmc6450775?pdf=renderCitation Count: 9
- Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease2018OPENTitle: Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0282-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-018-0282-4Citation Count: 194
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://manuscript.elsevier.com/S1353802018304310/pdf/S1353802018304310.pdfCitation Count: 16
-
OPENTitle: Abstracts from the 50th European Society of Human Genetics Conference: PostersJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 26Issue #: S1Start Page: 113End Page: 819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41431-018-0247-7Best OA location URL: https://www.nature.com/articles/s41431-018-0247-7.pdfCitation Count: 4
- Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson’s disease patients OFF and ON medications2018OPENTitle: Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson’s disease patients OFF and ON medicationsJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 119Issue #:Start Page: 24End Page: 33Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2018.07.024Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2018.07.024Citation Count: 15
-
OPENTitle: Importance of low diagnostic Accuracy for early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1551End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27485Best OA location URL: https://europepmc.org/articles/pmc6544441?pdf=renderCitation Count: 97
-
OPENTitle: Modulation of intracellular calcium signaling by microRNA-34a-5pJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-018-1050-7Best OA location URL: https://www.nature.com/articles/s41419-018-1050-7.pdfCitation Count: 28
- Regional vesicular acetylcholine transporter distribution in human brain: A [18F]fluoroethoxybenzovesamicol positron emission tomography study2018OPENTitle: Regional vesicular acetylcholine transporter distribution in human brain: A [18F]fluoroethoxybenzovesamicol positron emission tomography studyJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 526Issue #: 17Start Page: 2884End Page: 2897Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.24541Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/146604/1/cne24541.pdfCitation Count: 48
- CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorder2018OPENTitle: CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorderJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-018-0129-5Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-018-0129-5Citation Count: 11
-
OPENTitle: USP 14 inhibition corrects an in vivo model of impaired mitophagyJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201809014Best OA location URL: https://doi.org/10.15252/emmm.201809014Citation Count: 90
- Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)2018OPENTitle: Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 8Issue #: 4Start Page: 517End Page: 527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181434Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181434?id=journal-of-parkinsons-disease%2Fjpd181434Citation Count: 21
- Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat2018OPENTitle: Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the ratJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0066-0Best OA location URL: https://www.nature.com/articles/s41531-018-0066-0.pdfCitation Count: 52
-
OPENTitle: Lewy body pathology in Alzheimer's disease: A clinicopathological prospective studyJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 139Issue #: 1Start Page: 76End Page: 81Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.13028Best OA location URL: https://doi.org/10.1111/ane.13028Citation Count: 41
-
OPENTitle: Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's DiseaseJournal Name: PROTEOMICSPublisher: WileyVol: 18Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201800108Best OA location URL: https://europepmc.org/articles/pmc6283072?pdf=renderCitation Count: 61
- Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients2018OPENTitle: Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patientsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-31988-0Best OA location URL: https://www.nature.com/articles/s41598-018-31988-0.pdfCitation Count: 21
- Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders2018OPENTitle: Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative DisordersJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 320Issue #: 11Start Page: 1151End Page: 1151Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2018.12917Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2702872/jama_ossenkoppele_2018_pc_180007.pdfCitation Count: 361
-
OPENTitle: β2‐adrenoreceptor medications and risk of Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 5Start Page: 683End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25341Best OA location URL: https://europepmc.org/articles/pmc6881195?pdf=renderCitation Count: 69
- Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK22018OPENTitle: Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK2Journal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 19Issue #: 9Start Page: 2784End Page: 2784Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms19092784Best OA location URL: https://www.mdpi.com/1422-0067/19/9/2784/pdf?version=1537093660Citation Count: 2
-
OPENTitle: Common and rare GCH1 variants are associated with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 73Issue #:Start Page: 231.e1End Page: 231.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.09.008Best OA location URL: https://europepmc.org/articles/pmc6251729?pdf=renderCitation Count: 28